Good interview. My key takeaways:
- FDA, TGA, EU clearance as a medical device
- multi year strategy, so be patient, bright future
- clinical studies about to commence relating to the technology's feasibility for an older age range, could aim to compete with Akili
I know he can't see this. but. Good luck Glen, and keep up the good work!
Ann: Duke University and TALi Agreement, page-40
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TD1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.295M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $17 | 16.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 21760744 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 29073743 | 15 |
View Market Depth
| Last trade - 15.52pm 13/09/2024 (20 minute delay) ? |
| TD1 (ASX) Chart |